Checkpoint Inhibitors for Non-Small Cell Lung Cancer Among Older Adults.

about

Checkpoint blockade in solid tumors and B-cell malignancies, with special consideration of the role of CD200.Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical Trials

P2860

Q46971015-361D5B19-4A7A-4CE6-BC5A-E52EA7E0436E Q57173000-F38DB14A-43C7-47C0-B714-BEE81EC7B4FA

P2860

Checkpoint Inhibitors for Non-Small Cell Lung Cancer Among Older Adults.

Item

http://www.wikidata.org/entity/Q38654099

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Checkpoint Inhibitors for Non-Small Cell Lung Cancer Among Older Adults.

@en

type

Item

label

Checkpoint Inhibitors for Non-Small Cell Lung Cancer Among Older Adults.

@en

prefLabel

Checkpoint Inhibitors for Non-Small Cell Lung Cancer Among Older Adults.

@en

P1476

Checkpoint Inhibitors for Non-Small Cell Lung Cancer Among Older Adults.

@en

P2093

Carolyn Presley

http://www.w3.org/2001/XMLSchema#string

Joshua Morales

http://www.w3.org/2001/XMLSchema#string

Rawad Elias

http://www.w3.org/2001/XMLSchema#string

P2860

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

Ageing, autoimmunity and arthritis: Perturbations of TCR signal transduction pathways with ageing - a biochemical paradigm for the ageing immune system

CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial.

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

PD-1 and its ligands in tolerance and immunity

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells

PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells

P2888

s11912-017-0619-0

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-017-0619-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090914963

http://www.w3.org/2001/XMLSchema#string

P698

28755314

http://www.w3.org/2001/XMLSchema#string

Checkpoint Inhibitors for Non-Small Cell Lung Cancer Among Older Adults.

about

P2860

P2860

Checkpoint Inhibitors for Non-Small Cell Lung Cancer Among Older Adults.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698